ConductScience.org, home

Library / Genes

TRBV20OR9-2: T cell receptor beta variable 20/OR9-2 (non-functional)

0 proteins, 0 patents, 0 drugs, 0 trials, 20,044 NIH grants and 57,249 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolTRBV20OR9-2HGNC
NameT cell receptor beta variable 20/OR9-2 (non-functional)HGNC
NCBI Gene ID6962NCBI Gene
HGNC IDHGNC:12197HGNC
EnsemblENSG00000205274NCBI Gene
AliasesCDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O, TRBV20/OR9-2NCBI Gene
TypepseudoNCBI Gene

Proteins 0

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource

Patents 0

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 20044

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant4642,025NIH's project files
P30CA016672Cancer Center Support Grant2652,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award1022,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)1012,025NIH's project files
P30CA016042Cancer Center Support Grant962,025NIH's project files
U19AI057229Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro962,025NIH's project files
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged902,025NIH's project files
P30CA006973Regional Oncology Research Center852,025NIH's project files
P30CA016520Abramson Cancer Center Support Grant812,025NIH's project files
ZIABC010984Adoptive Cell Transfer Immunotherapy of Cancer782,025NIH's project files

Papers 57249

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42827453PubTator, text miningPubMed
42826196PubTator, text miningPubMed
42826174PubTator, text miningPubMed
42825518PubTator, text miningPubMed
42823159PubTator, text miningPubMed
42819907PubTator, text miningPubMed
42819770PubTator, text miningPubMed
42819241PubTator, text miningPubMed
42818511PubTator, text miningPubMed
42817982PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license